Opioid utilization patterns in United States individuals with sickle cell disease

被引：31
|
作者：
Ballas, Samir K. [1 ]
Kanter, Julie [2 ]
Agodoa, Irene [3 ]
Howard, Robin [3 ]
Wade, Sally [4 ]
Noxon, Virginia [5 ]
Dampier, Carlton [6 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Med Univ South Carolina, Charleston, SC 29425 USA
[3] Global Blood Therapeut, San Francisco, CA USA
[4] Wade Outcomes Res & Consulting, Salt Lake City, UT USA
[5] IBM Watson Hlth, Cambridge, MA USA
[6] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 10期
关键词：
D O I：
10.1002/ajh.25233
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E345 / E347
页数：3
相关论文
共 50 条
  • [31] Respiratory phenotype and health care utilization patterns by adults with sickle cell disease
    Agawu, Atu
    Nortey, Nii
    Jacobs, Charleen
    Zebrowski, Alexis
    Lin, Michelle P.
    Glassberg, Jeffrey
    BLOOD ADVANCES, 2025, 9 (01) : 143 - 150
  • [32] A MULTIDISCIPLINARY APPROACH TO IMPACT ACUTE CARE UTILIZATION AMONG INDIVIDUALS WITH SICKLE CELL DISEASE
    Powell, Rhea E.
    Axelrod, David
    Pulte, Elizabeth D.
    Lovett, Paris
    Crawford, Albert G.
    McAna, John
    Ward, Lawrence
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S99 - S100
  • [33] All-Cause Health Care Resource Utilization in Individuals with Sickle Cell Disease
    Rajpura, Jigar
    Thomas, Joseph, III
    BLOOD, 2015, 126 (23)
  • [34] Health care costs and utilization patterns of individuals with generalized anxiety disorder (GAD) in the United States
    Liu, GG
    Chen, SY
    Toh, S
    Cameron, AE
    Zhao, Z
    VALUE IN HEALTH, 2006, 9 (03) : A69 - A69
  • [35] Characterization of opioid use in sickle cell disease
    Han, Jin
    Zhou, Jifang
    Saraf, Santosh L.
    Gordeuk, Victor R.
    Calip, Gregory S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (05) : 479 - 486
  • [36] Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom
    Gladwin, Mark T.
    Barst, Robyn J.
    Gibbs, J. Simon R.
    Hildesheim, Mariana
    Sachdev, Vandana
    Nouraie, Mehdi
    Hassell, Kathryn L.
    Little, Jane A.
    Schraufnagel, Dean E.
    Krishnamurti, Lakshmanan
    Novelli, Enrico
    Girgis, Reda E.
    Morris, Claudia R.
    Rosenzweig, Erika Berman
    Badesch, David B.
    Lanzkron, Sophie
    Castro, Oswaldo L.
    Taylor, James G.
    Goldsmith, Jonathan C.
    Kato, Gregory J.
    Gordeuk, Victor R.
    Machado, Roberto F.
    PLOS ONE, 2014, 9 (07):
  • [37] Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States A Cost-Effectiveness Analysis
    Basu, Anirban
    Winn, Aaron N.
    Johnson, Kate M.
    Jiao, Boshen
    Devine, Beth
    Hankins, Jane S.
    Arnold, Staci D.
    Bender, M. A.
    Ramsey, Scott D.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (02) : 155 - 164
  • [38] Feasibility of Constructing an Interactive Mapping Tool to Visualize Sickle Cell Disease Geographic Distribution and Medical Care Utilization in the United States
    Werneiwski, Kendall
    Goel, Ruchika
    Gehrie, Eric A.
    BLOOD, 2023, 142
  • [39] An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States
    Wesevich, Austin
    Peek, Monica E.
    Ratain, Mark J.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (01) : 85 - 86
  • [40] Geographic differences in mortality of young children with sickle cell disease in the United States
    Davis, H
    Gergen, PJ
    Moore, RM
    PUBLIC HEALTH REPORTS, 1997, 112 (01) : 52 - 58
12345